M&A: Page
-
Courtesy of Evident/Olympus
Bain acquires Olympus life sciences unit for $3.1B
The company aims to expand its position as a workflow solution provider in life science and industrial markets.
By Susan Kelly • April 3, 2023 -
Neilson Barnard via Getty Images
Illumina urges shareholders to reject Icahn board nominees
The DNA-sequencing company says Icahn’s board nominees don’t understand its business or the regulatory process.
By Susan Kelly • March 31, 2023 -
Courtesy of Medtronic
ICU Medical challenges GE HealthCare for Medtronic units valued at $8B: report
Medtronic wants to spin off or sell the two units to focus on faster-growing parts of its business and is talking to potential buyers.
By Nick Paul Taylor • March 30, 2023 -
Getty Images
SonderMind acquires technology from Mindstrong ahead of digital health startup’s shutdown
Mindstrong’s collapse comes in a turbulent period for the digital health sector.
By Nick Paul Taylor • March 23, 2023 -
Getty Images
NuVasive shareholders expected to ‘begrudgingly’ back Globus’ $3.1B takeover amid lack of other bidders
Analysts said “none of the other major strategic players were in a position to bid on NuVasive — either because they were not interested or were financially tied up in other areas.”
By Nick Paul Taylor • March 22, 2023 -
Courtesy of Grail
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
The DNA-sequencing company said the activist investor hasn’t offered any better solutions for satisfying regulators’ concerns about the acquisition.
By Susan Kelly • March 20, 2023 -
Getty Images
Getinge buys sterilization firm Ultra Clean Systems for $16M
The Sweden-based company, which already partnered with Ultra Clean as a distributor, said the deal will “significantly expand” its offerings to sterile reprocessing departments.
By Elise Reuter • March 15, 2023 -
Mat Szwajikos via Getty Images
Illumina shares jump 17% after Icahn launches proxy fight
The activist investor said his board nominees would work to prevent Illumina from “sinking further into the quicksand” in a battle with regulators over the Grail acquisition.
By Susan Kelly • Updated March 14, 2023 -
Courtesy of Taewoong medical
Olympus agrees to $370M gastrointestinal stent takeover as medtech M&A rebound continues
The deal for Korea-based Taewoong, which makes stents used to help clear blockages, supports Olympus’ plan to expand in the GI market.
By Nick Paul Taylor • Feb. 28, 2023 -
Getty Images
Globus’ full-year sales top $1B as analysts continue to question wisdom of NuVasive takeover
Analysts raised concerns about Globus’ planned $3.1 billion takeover of spine specialist NuVasive, asking about the company’s “flexibility and willingness to close the deal.”
By Nick Paul Taylor • Feb. 23, 2023 -
Courtesy of Insulet Corp.
Insulet pays Bigfoot Biomedical $25M for pump-based automated insulin delivery technology
Insulet framed the Bigfoot deal as a way to double its IP portfolio and strengthen its position in the insulin pump market.
By Nick Paul Taylor • Feb. 14, 2023 -
Getty Images
GE HealthCare agrees to buy AI imaging firm Caption Health in second acquisition
GE HealthCare plans to pair its ultrasound machines with Caption’s applications for early disease detection.
By Elise Reuter • Feb. 10, 2023 -
Courtesy of Cardiovascular Systems Inc.
Abbott to pay $890M to acquire CSI, gaining atherectomy device
The deal expands Abbott’s vascular device lineup and access to additional products in development.
By Susan Kelly • Feb. 9, 2023 -
Globus agrees to buy NuVasive in stock deal valued at $3.1B, boosting spine business
The two firms expect their combined salesforce and shared operational strengths will better fend off competition.
By Elise Reuter • Updated Feb. 9, 2023 -
Getty Images
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Manufacturers that serve other industries are expected to move into medtech through mergers and acquisitions, driving up deal volumes.
By Nick Paul Taylor • Feb. 9, 2023 -
Getty Images
Medtech trends in 2023Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.
By Peter Green • Jan. 31, 2023 -
Getty Images
Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy
Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.
By Elise Reuter • Updated Jan. 18, 2023 -
Courtesy of Shockwave Medical
Shockwave to pay $100M for Neovasc, adding refractory angina treatment to device pipeline
Neovasc already has a CE mark for the device and last year said it was targeting a 2025 approval by the FDA.
By Nick Paul Taylor • Jan. 18, 2023 -
Getty Images
‘Mixed signals’ from medtech management suggest industry had bumpy end to 2022: analysts
The recovery of procedure volumes was “muted and uneven” in the fourth quarter with growth throttled by hospital staffing issues and worker absenteeism.
By Nick Paul Taylor • Jan. 13, 2023 -
Courtesy of Imactis
GE HealthCare to buy France’s IMACTIS in first acquisition as independent firm
IMACTIS’s CT-Navigation system is used to help surgeons in minimally invasive operations and reduce procedure time.
By Peter Green • Jan. 11, 2023 -
Permission granted by Medtronic
Medtronic CEO Martha: No more divestitures planned for 2023, but review continues
“The portfolio review is ongoing,” CEO Geoff Martha said, even as the world's largest medtech company plans to divest dialysis, respiratory interventions and patient monitoring businesses.
By Elise Reuter • Jan. 9, 2023 -
Getty Images
Baxter to spin off renal care, acute therapies units
The company is also considering the sale of its Biopharma Solutions business.
By Elise Reuter • Jan. 6, 2023 -
Courtesy of GE Healthcare
Q&AFriday Q&A: For GE HealthCare, the future is digital, CEO Arduini says
Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business.
By Peter Green • Jan. 6, 2023 -
Courtesy of Embody
Zimmer to acquire soft tissue repair firm Embody for as much as $275M
Buying Embody’s repair system for tendons and ligaments will expand Zimmer Biomet’s share in the growing sports medicine market.
By Elise Reuter • Jan. 5, 2023 -
Getty Images
Deep DiveA look back at medtech’s top 10 acquisitions of 2022
While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of deals declined from 2021.
By Elise Reuter • Dec. 22, 2022
Previous
